Bridgefront Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,998	Closed	-$486K	–	517
2024 Q2	$486K	Buy	1,998 +129	+7%	+$31.3K	0.2%	167
2024 Q1	$279K	Buy	+1,869	New	+$279K	0.21%	207
2022 Q4	–	Sell	-1,921	Closed	-$385K	–	357
2022 Q3	$385K	Buy	+1,921	New	+$385K	0.39%	78